RotaTeq 2200000 [iU]/2mL (Rotavirus Vaccine, Live, Oral, Pentavalent SOLUTION) 2200000 [iU]/2mL

RotaTeq 2200000 [iU]/2mL is a live, oral rotavirus vaccine designed for pediatric use. It helps protect against rotavirus infections, which are a common cause of severe diarrhea in young children.

Strength

2200000 [iU]/2mL

Pack Size

25 POUCH in 1 CARTON (0006-4047-20) / 1 TUBE in 1 POUCH (0006-4047-02) / 2 mL in 1 TUBE (0006-4047

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RotaTeq is used to prevent rotavirus infections in infants and young children. Rotavirus is a highly contagious virus that can cause severe diarrhea, vomiting, and dehydration. This vaccine is typically administered orally to help build immunity against the virus.

Side Effects

Common effects of RotaTeq may include mild gastrointestinal discomfort, such as diarrhea or vomiting, shortly after administration. Some children may also experience mild fever or irritability. These effects are usually temporary and resolve on their own.

Precautions & Warnings

RotaTeq should be administered under the guidance of a healthcare professional. It is important to follow the recommended schedule for vaccination. Individuals with certain medical conditions or allergies should consult their healthcare provider before receiving this vaccine.

Avoid Interactions

RotaTeq may interact with other medications or vaccines. It is important to inform your healthcare provider about any other medications or vaccines your child is receiving. Avoid administering other oral medications within a certain timeframe before or after receiving RotaTeq.

Frequently Asked Questions

RotaTeq is used to prevent rotavirus infections in infants and young children, which can cause severe diarrhea and dehydration.

RotaTeq is administered orally, typically in a series of doses as recommended by a healthcare professional.

Common side effects may include mild gastrointestinal discomfort, diarrhea, vomiting, fever, or irritability.

It is important to consult a healthcare provider about administering RotaTeq with other vaccines to avoid potential interactions.

Individuals with certain medical conditions or allergies should consult their healthcare provider before receiving RotaTeq.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.